Phase I study of PF-03446962, a fully human monoclonal antibody against activin receptor-like kinase-1, in patients with hepatocellular carcinoma
- Matteo Simonelli
- , P. Zucali
- , A. Santoro
- , M. B. Thomas
- , F. G. de Braud
- , H. Borghaei
- , J. Berlin
- , C. S. Denlinger
- , C. Noberasco
- , L. Rimassa
- , T. Y. Kim
- , P. A. English
- , A. Abbattista
- , C. Gallo Stampino
- , M. Carpentieri
- , J. A. Williams
- IRCCS Istituto Clinico Humanitas - Rozzano (Milano)
- Medical University of South Carolina
- IRCCS Istituto Europeo di Oncologia - Milano
- Vanderbilt University
- Fox Chase Cancer Center
- Seoul National University
- Pfizer Oncology
- Pfizer
Research output: Contribution to journal › Article › peer-review
35
Scopus
citations